Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

7.14 (USD) • At close December 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Assets:
Current Assets:
Cash & Cash Equivalents 128.10154.912346.07141.6995.995
Short Term Investments 104.312207.914000
Cash and Short Term Investments 232.413262.826346.07141.6995.995
Net Receivables 0.5057.656000
Inventory 00.96000
Other Current Assets 3.2945.4045.191.7923.764
Total Current Assets 236.212275.886348.66643.5919.759
Non-Current Assets:
Property, Plant & Equipment, Net 62.61161.90712.3254.6231.335
Goodwill 00000
Intangible Assets 00000
Goodwill and Intangible Assets 00000
Long Term Investments 04.3185.3381.1640
Tax Assets 00000
Other Non-Current Assets 4.9320.278000
Total Non-Current Assets 67.54366.50317.6635.7871.335
Total Assets 303.755342.389366.32949.37811.094
Liabilities & Equity:
Current Liabilities:
Account Payables 11.1527.8626.5587.0663.195
Short Term Debt 6.3246.254000.75
Tax Payables 00000
Deferred Revenue 17.6780000
Other Current Liabilities 11.43811.45310.0822.2090.347
Total Current Liabilities 46.59225.56916.63829.2754.292
Non-Current Liabilities:
Long Term Debt 42.87743.874067.7640
Deferred Revenue Non-Current 32.323001.0670
Deferred Tax Liabilities Non-Current 00000
Other Non-Current Liabilities 2.7131.5332.17600
Total Non-Current Liabilities 77.91345.4072.17668.83118.95
Total Liabilities 124.50570.97618.81498.10623.242
Equity:
Preferred Stock 00366.3290.0680.019
Common Stock 0.0050.0050.0050.0010.05
Retained Earnings -365.888-230.536-122.035-48.077-12.198
Accumulated Other Comprehensive Income/Loss -2.724-1.752-2.021-1.056-0.069
Other Total Stockholders Equity 547.857503.696471.5660.4040.05
Total Shareholders Equity 179.25271.413347.515-48.728-12.148
Total Equity 179.25271.413347.515-48.728-12.148
Total Liabilities & Shareholders Equity 303.755342.389366.32949.37811.094